azelnidipine has been researched along with Abdominal Aortic Aneurysm in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirata, Y; Kitagawa, T; Kurobe, H; Matsuoka, Y; Maxfield, MW; Sata, M; Sugasawa, N | 1 |
| Akashi, H; Aoyagi, S; Hiromatsu, S; Nakamura, E; Onitsuka, S; Tanaka, A | 1 |
| Akashi, H; Aoyagi, S; Hiromatsu, S; Kato, S; Yokokura, H | 1 |
3 other study(ies) available for azelnidipine and Abdominal Aortic Aneurysm
| Article | Year |
|---|---|
Azelnidipine suppresses the progression of aortic aneurysm in wild mice model through anti-inflammatory effects.
Topics: Aminopropionitrile; Angiotensin II; Animals; Anti-Inflammatory Agents; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Azetidinecarboxylic Acid; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Disease Progression; Inflammation Mediators; Macrophages; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Sirtuin 1; Time Factors; Tumor Necrosis Factor-alpha | 2013 |
Azelnidipine decreases plasma matrix metalloproteinase-9 levels after endovascular abdominal aortic aneurysm repair.
Topics: Aged; Aortic Aneurysm, Abdominal; Azetidinecarboxylic Acid; Blood Vessel Prosthesis Implantation; Calcium Channel Blockers; Dihydropyridines; Female; Humans; Male; Matrix Metalloproteinase 9; Middle Aged | 2009 |
Effects of calcium channel blocker azelnidipine on experimental abdominal aortic aneurysms.
Topics: Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Azetidinecarboxylic Acid; Calcium Channel Blockers; Dihydropyridines; Disease Models, Animal; Disease Progression; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Rats; Rats, Wistar | 2007 |